← Eichor
Study identifier: NCT02892877 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The French National Reference Centre of GTD

Condition: Neoplasm, Trophoblastic · Gestational Trophoblastic Disease · Hydatidiform Mole  ·  Sponsor: Hospices Civils de Lyon

PhaseN/A
Planned participants25500
Who can joinFemale, N/A to no upper limit
Healthy volunteersNo

About this study

The French Gestational Trophoblastic Disease (GTD) centre has been set up and active by registering, monitoring and treating women with GTD since november 1999. The aim is to improve the management of trophoblastic disease in France. About 850 new cases are registered each year and 140 women treated, mostly with chemotherapy and surgery. The center works as follow, based on a multidisciplinary approach. The policy is that patient remains followed by her local physician, but can be seen and treated in the Center at demand and that the registry is done on a voluntary basis. Each administrative french area has a local expert team (oncologist and gynaecologist) who is able to look after the patients with the help of the national reference center physicians based in Lyon. * Once a doctor discovers a molar pregnancy, he contacts the center, with the agreement of his patient, for an opinion, an advice or simply to report the case. * The center sends to the doctor the informed consent form to be signed by the patient, a registering form and information about pathology for patient and physician, and first guidelines based on initial pathology report. The patient remains followed by her gynecologist, who stays her first interlocutor throughout the whole process and she goes to her local laboratory for hCG monitoring; * A letter is sent to the initial pathology laboratory that originally carried the diagnosis of molar pregnancy to require slide sending to the pathologist referral …

This description comes directly from the study's public registry record.

Talk to the study team

François Golfier, Pr  ·  (0)4 78 86 66 78  ·  francois.golfier@chu-lyon.fr

Touria Hajri  ·  (0)4 78 86 66 78  ·  touria.hajri@chu-lyon.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Centre des Maladies Trophoblastiques Centre Hospitalier Lyon Sud-Bâtiment 3B-2ème étage, 165 Chemin du Grand RevoyetPierre-Bénite, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02892877